TABLE 2.
Efficacy of dietary supplements and risk of cardiovascular mortality1
| Factor (references) | Trials, n | RR | 95% CI | I2 (95% CI), % |
| Calcium (low dose, <1200 mg/d) (32, 72) | 2 | 0.81 | 0.04, 15.9 | 47 (NA) |
| Given singly | 1 | 3.48 | 0.18, 66.8 | NA |
| Combined with others | 1 | 0.17 | 0.01, 4.03 | NA |
| Selenium2 (54, 60, 86, 93) | 3 | 0.89 | 0.74, 1.06 | 0 (0, 90) |
| Given singly | 3 | 0.92 | 0.76, 1.13 | 0 |
| Combined with others | 1 | 0.82 | 0.64, 1.05 | NA |
| Low dose (<120 μg/d) | 1 | 0.75 | 0.32, 1.79 | NA |
| High dose (≥120 μg/d) | 2 | 0.90 | 0.75, 1.07 | 0 |
| Zinc2 (combined with others and low dose, <50 mg/d) (30) | 1 | 0.83 | 0.65, 1.05 | NA |
| Vitamin D (low dose, <500 IU/d) (32, 51, 68, 70) | 3 | 0.91 | 0.76, 1.09 | 0 (0, 90) |
| Given singly | 1 | 0.33 | 0.01, 7.96 | NA |
| Combined with others | 2 | 0.85 | 0.41, 1.76 | 9 |
| β-Carotene2 (30, 43, 44, 59, 80, 86, 89, 91) | 8 | 1.01 | 0.92, 1.10 | 7 (0, 71) |
| Given singly | 5 | 1.04 | 0.93, 1.16 | 0 |
| Combined with others | 4 | 0.95 | 0.84, 1.09 | 26 |
| Low dose (<30 mg/d) | 4 | 0.97 | 0.85, 1.10 | 29 |
| High dose (≥30 mg/d) | 4 | 1.06 | 0.93, 1.21 | 0 (0, 70) |
| Vitamin A (combined with others) (30, 43) | 2 | 0.97 | 0.78, 1.21 | 58 (NA) |
| Low dose (<25,000 IU/d) | 1 | 0.85 | 0.66, 1.09 | NA |
| High dose (≥25,000 IU/d) | 1 | 1.07 | 0.92, 1.24 | NA |
| Vitamin C2 (30, 65, 75, 86) | 4 | 0.96 | 0.82, 1.13 | 0 (0, 85) |
| Given singly | 1 | 1.06 | 0.83, 1.35 | NA |
| Combined with others | 4 | 0.94 | 0.80, 1.12 | 0 |
| Low dose (<500 mg/d) | 2 | 0.87 | 0.68, 1.12 | 0 |
| High dose (≥500 mg/d) | 2 | 1.03 | 0.84, 1.26 | 0 |
| Vitamin E2 (30, 48, 58, 60, 64, 65, 74, 75, 80, 86) | 10 | 0.88 | 0.80, 0.96 | 0 (0, 62) |
| Given singly | 7 | 0.88 | 0.79, 0.98 | 0 |
| Combined with others | 6 | 0.89 | 0.80, 1.00 | 0 |
| Low dose (<400 IU/d) | 4 | 0.87 | 0.76, 0.99 | 0 |
| High dose (≥400 IU/d) | 6 | 0.88 | 0.77, 1.01 | 8 |
| Folic acid (given singly and high dose, ≥5 mg/d) (50) | 1 | 1.00 | 0.66, 1.53 | NA |
| Vitamin K (32) | 1 | 0.34 | 0.01, 8.16 | NA |
| EPA (85) | 1 | 0.93 | 0.56, 1.55 | NA |
NA, not applicable.
Multiarm trials were combined.